Marc Grasso - 26 Jan 2022 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Reporting relationship: CFO, CBO
Issuer ticker: KURA
Reported as of: 26 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Jan 2022, 15:17:52 UTC
Next SEC filing: 09 Feb 2022
Source filing: View source filing
Reporting owner signature: Teresa Bair, Attorney-in-fact for Marc Grasso

Key filing fact

Marc Grasso filed Form 4 for Kura Oncology, Inc. (KURA) on 28 Jan 2022.

Key facts

This page summarizes Marc Grasso's Form 4 filing for Kura Oncology, Inc. (KURA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 Jan 2022, 15:17.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KURA transaction

Common Stock

Award

Transaction value: $0
Shares: +21,900
Change %
Price: $0.000000
Shares after: 21,900
Date: 26 Jan 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KURA transaction Derivative

Option to purchase common stock

Award

Transaction value: $0
Shares: +131,000
Change %
Price: $0.000000
Shares after: 131,000
Date: 26 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 131,000
Exercise price: $14.15
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26.

Footnote F2

This option vests in 48 equal monthly installments commencing on the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .